APT1 Inhibitor II, Cpd21 – Calbiochem

Descrição detalhada : A cell permeable acetylpiperazine derivative compound that acts as a selective and reversible inhibitor of lysophospholipase 1 (LYPLA1; IC50 = 840 nM, Ki = 300 nM) without affecting the activity of LYPLA2 and 25 other serine hydrolases in mouse BW5147 T cell hydridoma proteome. Shown to cause an almost complete inhibition (+90%) of LYPLA1 activity in lung, heart, and kidney (50 mg/kg, 3 h), and in HEK293T, and mouse T cells (~ 5 µM for 3 h)., A cell permeable acetylpiperazine derivative compound that acts as a selective and reversible inhibitor of lysophospholipase 1 (LYPLA1; IC50 = 840 nM, Ki = 300 nM) without affecting the activity of LYPLA2 and 25 other serine hydrolases in mouse BW5147 T cell hydridoma proteome. Shown to cause an almost complete inhibition (+90%) of LYPLA1 activity in lung, heart, and kidney (50 mg/kg, 3 h), and in HEK293T, and mouse T cells (~ 5 µM for 3 h).Please note that the molecular weight for this compound is batch-specific due to variable water content.
Sinónimos : APT1 Inhibitor II, Cpd21 - Calbiochem; LYPLA1 Inhibitor, Lysophospholipase Inhibitor
Fórmula molecula r: C18H17ClF3N3O3
Armazenamento : 2-8C; 2-8C
Embalagem : 1X1EA